Latest News
-
HBS Reporting
Bluebird Bio’s gene therapy for neurological disorder gets FDA panel backing
Jun 15, 2022June 9 (Reuters) – Advisers to the U.S. Food and Drug Administration on Thursday voted to...
-
HBS Reporting
UK says Mariupol at risk of cholera outbreak
Jun 15, 2022June 10 (Reuters) – Ukraine’s southern city of Mariupol is at risk of a major cholera...
-
HBS Reporting
Sanofi’s Dupixent gets U.S. approval to treat eczema in young children
Jun 9, 2022June 7 (Reuters) – The U.S. Food and Drug Administration approved the use of Sanofi (SASY.PA)...
-
HBS Reporting
Moderna says Omicron-targeted COVID shot shows better response
Jun 9, 2022June 8 (Reuters) – Moderna Inc (MRNA.O) said on Wednesday a new version of its coronavirus...
-
HBS Reporting
COVID vaccine rights waiver within reach, WTO chief says ahead of meeting
Jun 9, 2022GENEVA, June 8 (Reuters) – An international agreement on waiving intellectual property rights for COVID-19 vaccines...
-
HBS Reporting
‘Widen gaze from Ukraine’ to avert famine in Somalia, U.N. agency warns
Jun 8, 2022LONDON, June 7 (Reuters) – The world must “widen its gaze from the war in Ukraine”...
-
HBS Reporting
Guinea reports first H5N1 bird flu outbreaks on farms
Jun 8, 2022PARIS, June 7 (Reuters) – Guinea has reported six outbreaks of highly pathogenic H5N1 avian influenza,...
-
HBS Reporting
N.Korea reports 61,730 more people with fever amid COVID outbreak -KCNA
Jun 7, 2022SEOUL, June 7 (Reuters) – North Korea reported 61,730 more people with fever symptoms amid its...
-
HBS Reporting
Amarin to slash jobs as generic rivals dull U.S. prospects of heart drug
Jun 7, 2022(Reuters) -Amarin Corp Plc said on Monday it would cut its workforce by 40%, as the...
-
HBS Reporting
Urban Remedy recalls strawberry drink after U.S. Hepatitis A outbreak
Jun 7, 2022WASHINGTON, June 6 (Reuters) – Urban Remedy has recalled its strawberry hibiscus rose tea drink due...